Works matching Growth

Results: 5000
    1

    Study protocol: developing, disseminating, and implementing a core outcome set for selective fetal growth restriction in monochorionic twin pregnancies.

    Published in:
    2019
    By:
    • Khalil, Asma;
    • Duffy, James M. N.;
    • Perry, Helen;
    • Ganzevoort, Wessel;
    • Reed, Keith;
    • Baschat, Ahmet A.;
    • Deprest, Jan;
    • Gratacos, Eduardo;
    • Hecher, Kurt;
    • Lewi, Liesbeth;
    • Lopriore, Enrico;
    • Oepkes, Dick;
    • Papageorghiou, Aris;
    • Gordijn, Sanne J.;
    • International Collaboration to Harmonise Outcomes for Selective Fetal Growth Restriction (CHOOSE-FGR)
    Publication type:
    journal article
    2
    3
    4
    5
    6
    7
    8
    9
    10

    Impact of an integrated nutrition, health, water sanitation and hygiene, psychosocial care and support intervention package delivered during the pre- and peri-conception period and/or during pregnancy and early childhood on linear growth of infants in the first two years of life, birth outcomes and nutritional status of mothers: study protocol of a factorial, individually randomized controlled trial in India.

    Published in:
    2020
    By:
    • Taneja, Sunita;
    • Chowdhury, Ranadip;
    • Dhabhai, Neeta;
    • Mazumder, Sarmila;
    • Upadhyay, Ravi Prakash;
    • Sharma, Sitanshi;
    • Dewan, Rupali;
    • Mittal, Pratima;
    • Chellani, Harish;
    • Bahl, Rajiv;
    • Bhan, Maharaj Kishan;
    • Bhandari, Nita;
    • on behalf of the Women and Infants Integrated Growth Study (WINGS) Group;
    • Rafiqui, Farhana;
    • Kaur, Jasmine;
    • Aggarwal, Gunjan;
    • Arya, Nikita;
    • Kate, Anita;
    • Shekhar, Medha;
    • Verma, Shruti
    Publication type:
    journal article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46

    Combining antivascular endothelial growth factor and anti-epidermal growth factor receptor antibodies: randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer (ECOG-ACRIN E7208).

    Published in:
    JNCI: Journal of the National Cancer Institute, 2024, v. 116, n. 9, p. 1487, doi. 10.1093/jnci/djae114
    By:
    • Hochster, Howard S;
    • Catalano, Paul;
    • Weitz, Michelle;
    • Mitchell, Edith P;
    • Cohen, Deirdre;
    • O'Dwyer, Peter J;
    • Faller, Bryan A;
    • Kortmansky, Jeremy S;
    • O'Hara, Mark H;
    • Kricher, Sheetal M;
    • Lacy, Jill;
    • Lenz, Heinz-Josef;
    • Verma, Udit;
    • Benson, Al B
    Publication type:
    Article
    47
    48
    49
    50